Clinical Trials Logo

Dry Eye Syndromes clinical trials

View clinical trials related to Dry Eye Syndromes.

Filter by:

NCT ID: NCT02078661 Completed - Dry Eye Syndrome Clinical Trials

Safety and Efficacy of PG101 for Dry Eye Syndrome

PG101
Start date: December 2013
Phase: Phase 1/Phase 2
Study type: Interventional

To evaluate the safety and efficacy of 0.25% PG101 and 1.0% PG101 topical gel suspension compared to placebo when administered two times daily for 14 days in subjects diagnosed with dry eye syndrome

NCT ID: NCT02066051 Completed - Dry Eye Syndrome Clinical Trials

IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD

Start date: October 2013
Phase: N/A
Study type: Interventional

The purpose of this study was to see if Intense Pulsed Light (IPL) can be used safely and effectively to help treat dry eyes from ocular rosacea after chronic graft-versus-host disease (GVHD). Current treatment options for this disease are limited.

NCT ID: NCT02051023 Completed - Dry Eye Clinical Trials

Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca)

FML
Start date: February 2014
Phase: Phase 3
Study type: Interventional

Hypothesis: Fluorometholone (FML) 0.1% eyedrops topically applied 4 times a day for 22 days is more efficient than artificial tears (Liquifilm) in dry eye disease (DED) and ameliorates the worsening of the disease after exposure to an adverse controlled environment.

NCT ID: NCT02042820 Completed - Dry Eye Disease Clinical Trials

Ocular Surface Immune Response in Dry Eye Disease

Start date: January 2014
Phase: N/A
Study type: Observational

In vivo confocal microscopy (IVCM) is a sensitive imaging tool for detecting dry eye-associated subclinical inflammation. Studies have previously shown that IVCM provides an in vivo metric to measure inflammatory changes in the central cornea. The objective of the current study is to assess inflammatory response changes in the peripheral cornea and the conjunctiva by analyzing epithelial immune cell density and morphology in these areas and then correlating the IVCM findings to clinical signs and symptoms to establish novel objective imaging biomarkers.

NCT ID: NCT02040623 Completed - Clinical trials for Chronic Graft-versus-host Disease

Safety and Efficacy Study of R932348 Ophthalmic Solution in Chronic Ocular Graft Versus Host Disease Patients(DROPS-2)

DROPS-2
Start date: March 2014
Phase: Phase 2
Study type: Interventional

- To assess the efficacy of R348 Ophthalmic Solutions administered for 12 weeks to subjects evaluated by objective and subjective measures. - To investigate the safety and tolerability of R348 Ophthalmic Solutions administered for 12 weeks to subjects.

NCT ID: NCT02028754 Completed - Cataract Clinical Trials

A Study of Sodium Carboxymethylcellulose for Post Cataract Surgery Dry Eye Symptoms

RLOTUS
Start date: July 2011
Phase: Phase 4
Study type: Interventional

This study will evaluate the effect of sodium carboxymethylcellulose eye drops in the treatment of dry eye after cataract surgery.

NCT ID: NCT02023268 Completed - Dry Eye Syndrome Clinical Trials

Efficacy and Safety of T2762 and Vismed® in Dry Eye Syndrome

Start date: December 2013
Phase: Phase 3
Study type: Interventional

Comparison of the efficacy and safety of T2762 and Vismed® in the treatment of moderate to severe Dry Eye Syndrome

NCT ID: NCT02014922 Completed - Dry Eye Syndromes Clinical Trials

A Study to Determine the Relief of Dry Eye Symptoms With the Use of TheraTears® Products (DUNLIN)

DUNLIN
Start date: December 2013
Phase: Phase 4
Study type: Interventional

Dry eye is a very common condition that most often affects women and the elderly, and can be caused when the eyes do not produce enough tears, or when the tears evaporate too quickly. Although there isn't a simple cure for dry eye, there are numerous products on the market that attempt to help relieve some of the discomfort caused by this condition. Some of these products include artificial tears, omega-3 supplements, and/or anti-inflammatory medications. The purpose of this study is to evaluate the performance of a combination of TheraTears® products, and to compare them with the product(s) you have been using.

NCT ID: NCT02011776 Completed - Dry Eye Syndromes Clinical Trials

A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Syndrome

Start date: March 2013
Phase: N/A
Study type: Observational [Patient Registry]

The purpose of this study is to evaluate the effectiveness of fluorometholone combined with sodium hyaluronate eye drops in the treatment of Sjögren syndrome.

NCT ID: NCT02004067 Completed - Clinical trials for Evaporative Dry Eye Disease

Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease

Start date: January 2013
Phase: Phase 4
Study type: Interventional

In the present study the investigators aim to determine the efficacy of an immunomodulating topical medication, compared with a topical lubricant, on the treatment of dry eye disease (DED) due to primary or secondary Sjögren's syndrome (aqueous deficient DED) and evaporative DED.